Moderna, Inc.MRNANASDAQ
Loading
EPS Growth Under PressureDecelerating
Percentile Rank9
Year-over-Year Change
Year-over-year earnings per share growth rate
Percentile
P9
Near historical low
vs 3Y Ago
-7.3x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -313.73% |
| Q3 2025 | 76.06% |
| Q2 2025 | 15.48% |
| Q1 2025 | 13.40% |
| Q4 2024 | -8709.47% |
| Q3 2024 | 101.02% |
| Q2 2024 | -8.12% |
| Q1 2024 | -640.35% |
| Q4 2023 | 105.98% |
| Q3 2023 | -163.26% |
| Q2 2023 | -1910.00% |
| Q1 2023 | -94.75% |
| Q4 2022 | 42.70% |
| Q3 2022 | -51.89% |
| Q2 2022 | -38.94% |
| Q1 2022 | -24.44% |
| Q4 2021 | 45.47% |
| Q3 2021 | 19.34% |
| Q2 2021 | 127.21% |
| Q1 2021 | 542.03% |
| Q4 2020 | -16.95% |
| Q3 2020 | -90.32% |
| Q2 2020 | 11.43% |
| Q1 2020 | 5.41% |
| Q4 2019 | 0.00% |
| Q3 2019 | 9.76% |
| Q2 2019 | -2.50% |
| Q1 2019 | 9.09% |
| Q4 2018 | -62.96% |
| Q3 2018 | -12.50% |
| Q2 2018 | -26.32% |
| Q1 2018 | -46.15% |
| Q4 2017 | 87.62% |
| Q3 2017 | 16.00% |
| Q2 2017 | 0.00% |
| Q1 2017 | 0.00% |